Research, News & Discoveries
-
Faculty meeting highlights VUSM’s academic successes
Jun. 6, 2019, 8:32 AM Award winners pose for a photo at last week’s Spring Faculty Meeting. (photo by Anne Rayner) by Kathy Whitney Jeff Balser, MD, PhD, President and CEO of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine, kicked off the Spring Faculty Meeting… Read MoreJun. 6, 2019
-
Study details regulation of a multi-drug transporter
May. 29, 2019, 9:18 AM (left to right): Reza Dastvan, PhD, Smriti Mishra, PhD, and Hassane Mchaourab, PhD, are studying the inner workings of a protein pump that contributes to cancer chemotherapy resistance. by Leigh MacMillan Vanderbilt University researchers have discovered how a protein pump distinguishes between chemicals that it… Read MoreJun. 4, 2019
-
Flu’s “hidden target” may lead to universal vaccine: study
May. 16, 2019, 12:47 PM by Bill Snyder Researchers at Vanderbilt University Medical Center and the Scripps Research Institute in La Jolla, California, have discovered a “hidden target” on the surface of the hypervariable influenza A virus that could lead to better ways to prevent and treat the flu. Because… Read MoreJun. 4, 2019
-
Functional Insights Into a Major Drug-Resistance Transporter
As a member of the class of ABC (ATP-binding cassette) transporters, the P-glycoprotein (P-gp) harnesses energy from ATP hydrolysis to power conformational changes that transfer substrates across the cell membrane against a concentration gradient. P-gp transports more than 200 structurally diverse substrates, thereby playing a role in the pharmacokinetics of… Read MoreMay. 30, 2019
-
The dynamic basement
May. 9, 2019, 10:30 AM by Sanjay Mishra Basement membranes are an ancient form of extracellular matrix composed of complex biological molecules including Collagen IV. As important structural and functional components of tissues, basement membranes are subject to environmental damage, but little is known about how they are repaired. Now, a… Read MoreMay. 9, 2019
-
New trans-institutional program to focus on genetic variations, disease
May. 9, 2019, 9:03 AM From left, Brinda Selvaraj, Jonathan Sheehan, PhD, Hassane Mchaourab, PhD, and colleagues are part of the new trans-institutional Program in the Molecular Basis of Genetic Diseases. (photo by Steve Green) by Bill Snyder Vanderbilt has established a program to help researchers determine more precisely how… Read MoreMay. 9, 2019
-
Basu & Zhang awarded prestigious Goldwater Scholarships
May. 8, 2019, 8:53 AM Vanderbilt University sophomore Aakash Basu and junior Eric Zhang have been named Goldwater Scholars. The Goldwater Scholarship is the premier award for undergraduate STEM students who show exceptional promise of becoming the nation’s next generation of research leaders. Basu and Zhang were selected from a… Read MoreMay. 8, 2019
-
Johnson one of six new endowed chairs
by Kate Derrick May. 3, 2019, 8:15 AM (L to r) Brian T. McCann, Matthew S. Freiberg, Provost Susan R. Wente, Edward Wright-Rios, Ben Ho Park, Owen D. Jones, Carl H. Johnson (Joe Howell/Vanderbilt University) Vanderbilt’s six newest endowed chairs were honored by colleagues,… Read MoreMay. 3, 2019
-
Wilson appointed to ASGCT board of directors
May. 2, 2019, 8:33 AM by Kelsey Herbers The American Society of Gene and Cell Therapy (ASGCT) has appointed Matthew Wilson, MD, PhD, associate professor of Medicine in Vanderbilt’s Division of Nephrology and Hypertension, to its board of directors. Beginning in May 2019, Wilson will serve a three-year term as… Read MoreMay. 3, 2019
-
A new antibiotic’s mechanism of action
Apr. 25, 2019, 11:30 AM by Leigh MacMillan The novel antibacterial drug gepotidacin is showing clinical promise for the treatment of skin infections and gonorrhea. Gepotidacin was developed in response to the rising bacterial resistance to fluoroquinolone drugs such as ciprofloxacin. Like fluoroquinolones, gepotidacin acts on the bacterial enzymes gyrase… Read MoreMay. 3, 2019